Hospital Patient Safety Indicator Report (HPSIR) for Nenagh Hospital - March 2026
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked if the HSE maintains regional service demand projections for addiction services. Read the HSE response.
Deputy O'Flynn asked if any healthcare pathways have been identified as operating without complete national outcome datasets. Read the HSE response.
Deputy O'Flynn asked about the reimbursement of omaveloxolone (Skyclarys). Read the HSE response.
Deputy O'Flynn asked if any hospitals, hospital groups, or neurology centres currently facilitate access to omaveloxolone (skyclarys). Read the HSE response.
Deputy O'Flynn asked about approval thresholds that apply to the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked if clinical outcomes, complication rates or patient satisfaction for patients availing of the treatment abroad scheme are collected.
Deputy O'Flynn asked if the HSE carries out comparative benchmarking of treatment costs between different jurisdictions under the treatment abroad scheme.
Deputy O'Flynn asked if an audit has been conducted into value-for-money, expenditure controls or financial governance under the treatment abroad scheme.